Magnetic resonance spectroscopy in myocardial disease

References

• Bittl JA, Ingwall JS. Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31P NMR magnetization transfer study. J. Biol. Chem.260(6), 3512–3517 (1985).
   PubMed Web of Science ®Google Scholar
• Bottomley PA. MR spectroscopy of the human heart: the status and the challenges. Radiology191(3), 593–612 (1994).
   PubMed Web of Science ®Google Scholar
• Shivu GN, Abozguia K, Phan TT et al. 31P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: experiences at 3T. Eur. J. Radiol. (2008) (Epub ahead of print).
   PubMedGoogle Scholar
• Bottomley PA, Atalar E, Weiss RG. Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy. Magn. Reson. Med.35(5), 664–670 (1996).
   PubMed Web of Science ®Google Scholar
• Bottomley PA, Hardy CJ, Roemer PB. Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance. Magn. Reson. Med.14(3), 425–434 (1990).
   PubMed Web of Science ®Google Scholar
• Bottomley PA, Ouwerkerk R, Lee RF et al. Four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn. Reson. Med.47(5), 850–863 (2002).
   PubMed Web of Science ®Google Scholar
• Kohler SJ, Perry SB, Stewart LC et al. Analysis of 23Na NMR spectra from isolated perfused hearts. Magn. Reson. Med.18(1), 15–27 (1991).
   PubMed Web of Science ®Google Scholar
• Jansen MA, Van Emous JG, Nederhoff MG et al. Assessment of myocardial viability by intracellular 23Na magnetic resonance imaging. Circulation110(22), 3457–3464 (2004).
   PubMed Web of Science ®Google Scholar
• Bottomley PA, Weiss RG. Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium. Radiology219(2), 411–418 (2001).
   PubMed Web of Science ®Google Scholar
• Weiss RG, Bottomley PA, Hardy CJ et al. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N. Engl. J. Med.323(23), 1593–1600 (1990).
   PubMed Web of Science ®Google Scholar
• Yabe T, Mitsunami K, Okada M et al. Detection of myocardial ischemia by 31P magnetic resonance spectroscopy during handgrip exercise. Circulation89(4), 1709–1716 (1994).
   PubMed Web of Science ®Google Scholar
• Bottomley PA, Herfkens RJ, Smith LS et al. Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy. Radiology165(3), 703–707 (1987).
   PubMed Web of Science ®Google Scholar
• Bottomley PA, Wu KC, Gerstenblith G et al. Reduced myocardial creatine kinase flux in human myocardial infarction: an in vivo phosphorus magnetic resonance spectroscopy study. Circulation119(14), 1918–1924 (2009).
   PubMed Web of Science ®Google Scholar
• Yabe T, Mitsunami K, Inubushi T et al. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy. Circulation92(1), 15–23 (1995).
   PubMed Web of Science ®Google Scholar
• Ouwerkerk R, Bottomley PA, Solaiyappan M et al. Tissue sodium concentration in myocardial infarction in humans: a quantitative 23Na MR imaging study. Radiology248(1), 88–96 (2008).
   PubMed Web of Science ®Google Scholar
• Johnson BD, Shaw LJ, Buchthal SD et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation109(24), 2993–2999 (2004).
   PubMed Web of Science ®Google Scholar
• de Roos A, Doornbos J, Luyten PR et al. Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy. J. Magn. Reson. Imaging2(6), 711–719 (1992).
   PubMed Web of Science ®Google Scholar
• Masuda Y, Tateno Y, Ikehira H et al. High-energy phosphate metabolism of the myocardium in normal subjects and patients with various cardiomyopathies – the study using ECG gated MR spectroscopy with a localization technique. Jpn Circ. J.56(6), 620–626 (1992).
   PubMedGoogle Scholar
• Schaefer S, Gober JR, Schwartz GG et al.In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease. Am. J. Cardiol.65(16), 1154–1161 (1990).
   PubMed Web of Science ®Google Scholar
• Neubauer S, Krahe T, Schindler R et al.31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation86(6), 1810–1818 (1992).
   PubMed Web of Science ®Google Scholar
• Neubauer S, Horn M, Cramer M et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation96(7), 2190–2196 (1997).
   PubMed Web of Science ®Google Scholar
• Lee L, Horowitz J, Frenneaux M. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur. Heart J.25(8), 634–641 (2004).
   PubMed Web of Science ®Google Scholar
• Fragasso G, Perseghin G, De Cobelli F et al. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. Eur. Heart J.27(8), 942–948 (2006).
   PubMed Web of Science ®Google Scholar
• Crilley JG, Boehm EA, Blair E et al. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J. Am. Coll. Cardiol.41(10), 1776–1782 (2003).
   PubMed Web of Science ®Google Scholar
• Jung WI, Sieverding L, Breuer J et al.31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation97(25), 2536–2542 (1998).
   PubMed Web of Science ®Google Scholar
• Esposito A, De Cobelli F, Perseghin G et al. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging. Heart95(3), 228–233 (2009).
   PubMed Web of Science ®Google Scholar
• Lamb HJ, Beyerbacht HP, van der Laarse A et al. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation99(17), 2261–2267 (1999).
   PubMed Web of Science ®Google Scholar
• Smith CS, Bottomley PA, Schulman SP et al. Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation114(11), 1151–1158 (2006).
   PubMed Web of Science ®Google Scholar
• Perseghin G, De Cobelli F, Esposito A et al. Effect of the sporting discipline on the right and left ventricular morphology and function of elite male track runners: a magnetic resonance imaging and phosphorus 31 spectroscopy study. Am. Heart J.154(5), 937–942 (2007).
   PubMed Web of Science ®Google Scholar
• Klug G, Zwick RH, Frick M et al. Impact of exercise capacity on myocardial high-energy phosphate metabolism. Int. J. Sports Med.28(8), 667–672 (2007).
   PubMed Web of Science ®Google Scholar
• Phan TT, Abozguia K, Nallur SG et al. Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. J. Am. Coll. Cardiol.54(5), 402–409 (2009).
   PubMed Web of Science ®Google Scholar
• Conway MA, Allis J, Ouwerkerk R et al. Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Lancet338(8773), 973–976 (1991).
   PubMed Web of Science ®Google Scholar
• Neubauer S, Horn M, Pabst T et al. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy. J. Investig. Med.45(8), 453–462 (1997).
   PubMed Web of Science ®Google Scholar
• Beyerbacht HP, Lamb HJ, van der Laarse A et al. Aortic valve replacement in patients with aortic valve stenosis improves myocardial metabolism and diastolic function. Radiology219(3), 637–643 (2001).
   PubMed Web of Science ®Google Scholar
• Conway MA, Bottomley PA, Ouwerkerk R et al. Mitral regurgitation: impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans. Circulation97(17), 1716–1723 (1998).
   PubMed Web of Science ®Google Scholar
• Scheuermann-Freestone M, Madsen PL, Manners D et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with Type 2 diabetes. Circulation107(24), 3040–3046 (2003).
   PubMed Web of Science ®Google Scholar
• Diamant M, Lamb HJ, Groeneveld Y et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled Type 2 diabetes mellitus. J. Am. Coll. Cardiol.42(2), 328–335 (2003).
   PubMed Web of Science ®Google Scholar
• Alpert MA, Lambert CR, Panayiotou H et al. Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am. J. Cardiol.76(16), 1194–1197 (1995).
   PubMed Web of Science ®Google Scholar
• Hammer S, Snel M, Lamb HJ et al. Prolonged caloric restriction in obese patients with Type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J. Am. Coll. Cardiol.52(12), 1006–1012 (2008).
   PubMed Web of Science ®Google Scholar
• Walpoth BH, Tschopp A, Lazeyras F et al. Magnetic resonance spectroscopy for assessing myocardial rejection in the transplanted rat heart. J. Heart Lung Transplant12(2), 271–282 (1993).
   PubMed Web of Science ®Google Scholar
• Walpoth BH, Muller MF, Celik B et al. Assessment of cardiac rejection by MR-imaging and MR-spectroscopy. Eur. J. Cardiothorac. Surg.14(4), 426–430 (1998).
   PubMed Web of Science ®Google Scholar
• Van Dobbenburgh JO, De Groot MC, De Jonge N et al. Myocardial high-energy phosphate metabolism in heart transplant patients is temporarily altered irrespective of rejection. NMR Biomed.12(8), 515–524 (1999).
   PubMed Web of Science ®Google Scholar
• Caus T, Kober F, Mouly-Bandini A et al.31P MRS of heart grafts provides metabolic markers of early dysfunction. Eur. J. Cardiothorac. Surg.28(4), 576–580 (2005).
   PubMed Web of Science ®Google Scholar
• Merritt ME, Harrison C, Storey C et al. Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR. Proc. Natl Acad. Sci. USA104(50), 19773–19777 (2007).
   PubMed Web of Science ®Google Scholar